Insulin-like growth factor-binding protein-5 (IGFBP-5) inhibits TNF-α-induced NF-κB activity by binding to TNFR1

Biochemical and Biophysical Research Communications

Volumn 405, Issue 4, 2011, Pages 545-551

  Hwang, Jae Ryoung ^a   Huh, Jae Ho ^a,d   Lee, Yoonna ^a   Lee, Sang Il ^a   Rho, Seung Bae ^b   Lee, Je Ho ^a,c  

^a Sungkyunkwan University   (South Korea)

^b National Cancer Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Celltrion Inc   (South Korea)

Author keywords

IGFBP 5; NF B signaling pathway; TNF ; TNF inhibitor; TNF receptor 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; SOMATOMEDIN BINDING PROTEIN 5; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79951947266     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.064     Document Type: Article

References (20)

1. Lochrie J.D., Phillips K., Tonner E., et al. Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells. J. Cell. Physiol. 2006, 207:471-479.
2. Tripathi G., Salih D.A., Drozd A.C., et al. IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo. FASEB J. 2009, 23:2616-2626.
3. Akkiprik M., Hu L., Sahin A., et al. The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer. BMC Cancer 2009, 9:103.
4. Akkiprik M., Feng Y., Wang H., et al. Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer. Breast Cancer Res. 2008, 10:212.
5. Beattie J., Allan G.J., Lochrie J.D., et al. Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem. J. 2006, 395:1-19.
6. Graham M.E., Kilby D.M., Firth S.M., et al. The in vivo phosphorylation and glycosylation of human insulin-like growth factor-binding protein-5. Mol. Cell. Proteomics 2007, 6:1392-1405.
7. Standker L., Wobst P., Mark S., et al. Isolation and characterization of circulating 13-kDa C-terminal fragments of human insulin-like growth factor binding protein-5. FEBS Lett. 1998, 441:281-286.
8. Kanzaki S., Hilliker S., Baylink D.J., et al. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 1994, 134:383-392.
9. Thrailkill K.M., Quarles L.D., Nagase H., et al. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 1995, 136:3527-3533.
10. Loechel F., Fox J.W., Murphy G., et al. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem. Biophys. Res. Commun. 2000, 278:511-515.
11. Balkwill F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 2009, 9:361-371.
12. Heyninck K., Beyaert R. Crosstalk between NF-kappaB-activating and apoptosis-inducing proteins of the TNF-receptor complex. Mol. Cell Biol. Res. Commun. 2001, 4:259-265.
13. Bradley J.R. TNF-mediated inflammatory disease. J. Pathol. 2008, 214:149-160.
14. Higuchi M., Aggarwal B.B. TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J. Immunol. 1994, 152:3550-3558.
15. Kafert S., Winzen R., Loos A., et al. Protein binding regions of the mRNAs for the 55 kDa tumor necrosis factor receptor and the glucose transporter 1: sequence homology and competition for cellular proteins. FEBS Lett. 1998, 421:2-6.
16. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 1990, 10:2327-2334.
17. Twigg S.M., Kiefer M.C., Zapf J., et al. A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit. Endocrinology 2000, 141:454-457.
18. Coverley J.A., Baxter R.C. Phosphorylation of insulin-like growth factor binding proteins. Mol. Cell. Endocrinol. 1997, 128:1-5.
19. Conover C.A., Kiefer M.C. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J. Clin. Endocrinol. Metab. 1993, 76:1153-1159.
20. Andress D.L. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am. J. Physiol. 1998, 274:E744-E750.